| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 142 | 2026 | 1977 | 11.320 |
Why?
|
| Lung | 155 | 2026 | 4141 | 6.000 |
Why?
|
| Pulmonary Emphysema | 30 | 2020 | 277 | 3.990 |
Why?
|
| Pulmonary Artery | 63 | 2025 | 1132 | 3.810 |
Why?
|
| Smoking | 37 | 2020 | 1483 | 2.730 |
Why?
|
| Apoptosis | 52 | 2026 | 2454 | 2.580 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 27 | 2020 | 928 | 2.520 |
Why?
|
| Endothelium, Vascular | 43 | 2023 | 959 | 2.500 |
Why?
|
| Pulmonary Alveoli | 34 | 2021 | 389 | 2.470 |
Why?
|
| Hypoxia | 32 | 2025 | 1208 | 2.310 |
Why?
|
| Heart Ventricles | 10 | 2021 | 767 | 1.920 |
Why?
|
| Vascular Remodeling | 11 | 2024 | 209 | 1.830 |
Why?
|
| Oxidative Stress | 34 | 2019 | 1368 | 1.820 |
Why?
|
| Animals | 219 | 2026 | 38410 | 1.760 |
Why?
|
| Lung Diseases | 27 | 2026 | 787 | 1.630 |
Why?
|
| Acute Lung Injury | 12 | 2023 | 312 | 1.620 |
Why?
|
| Schistosomiasis | 10 | 2026 | 53 | 1.590 |
Why?
|
| Muscle, Smooth, Vascular | 17 | 2020 | 450 | 1.550 |
Why?
|
| Transforming Growth Factor beta | 13 | 2020 | 475 | 1.500 |
Why?
|
| Ceramides | 8 | 2023 | 117 | 1.340 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 11 | 2016 | 51 | 1.330 |
Why?
|
| Schistosoma mansoni | 8 | 2026 | 45 | 1.330 |
Why?
|
| Disease Models, Animal | 55 | 2026 | 4604 | 1.290 |
Why?
|
| Endothelial Cells | 29 | 2023 | 886 | 1.290 |
Why?
|
| Mice, Inbred C57BL | 52 | 2026 | 6041 | 1.270 |
Why?
|
| Emphysema | 15 | 2013 | 100 | 1.270 |
Why?
|
| Mice | 118 | 2026 | 18491 | 1.220 |
Why?
|
| alpha 1-Antitrypsin | 5 | 2013 | 104 | 1.090 |
Why?
|
| Humans | 253 | 2026 | 147293 | 1.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 23 | 2022 | 552 | 1.070 |
Why?
|
| Signal Transduction | 41 | 2026 | 5272 | 1.070 |
Why?
|
| Smoke | 9 | 2020 | 148 | 1.050 |
Why?
|
| Scleroderma, Systemic | 6 | 2022 | 123 | 1.020 |
Why?
|
| Familial Primary Pulmonary Hypertension | 15 | 2024 | 196 | 0.990 |
Why?
|
| Endothelial Growth Factors | 12 | 2002 | 62 | 0.980 |
Why?
|
| Alveolar Epithelial Cells | 9 | 2023 | 121 | 0.980 |
Why?
|
| Lymphokines | 12 | 2002 | 128 | 0.970 |
Why?
|
| Rats | 57 | 2024 | 5613 | 0.920 |
Why?
|
| Schistosomiasis mansoni | 5 | 2026 | 28 | 0.900 |
Why?
|
| Inflammation | 36 | 2025 | 2920 | 0.880 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 9 | 2023 | 300 | 0.870 |
Why?
|
| Mice, Knockout | 36 | 2026 | 3153 | 0.850 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 18 | 2015 | 109 | 0.800 |
Why?
|
| Receptors, Growth Factor | 9 | 2002 | 53 | 0.790 |
Why?
|
| Myocytes, Smooth Muscle | 7 | 2024 | 274 | 0.790 |
Why?
|
| Rats, Sprague-Dawley | 40 | 2024 | 2542 | 0.790 |
Why?
|
| Hypertrophy, Right Ventricular | 11 | 2024 | 152 | 0.750 |
Why?
|
| Fibroblasts | 10 | 2026 | 1039 | 0.750 |
Why?
|
| Lung Injury | 9 | 2019 | 262 | 0.730 |
Why?
|
| Microcirculation | 4 | 2019 | 142 | 0.720 |
Why?
|
| NF-E2-Related Factor 2 | 12 | 2016 | 103 | 0.720 |
Why?
|
| Pulmonary Veins | 4 | 2013 | 112 | 0.700 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 2024 | 11 | 0.690 |
Why?
|
| Transcription Factors | 8 | 2017 | 1747 | 0.690 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 9 | 2002 | 231 | 0.690 |
Why?
|
| Epithelial Cells | 16 | 2021 | 1141 | 0.680 |
Why?
|
| DNA-Binding Proteins | 7 | 2017 | 1488 | 0.680 |
Why?
|
| Up-Regulation | 11 | 2020 | 848 | 0.670 |
Why?
|
| Cigarette Smoking | 3 | 2020 | 103 | 0.670 |
Why?
|
| Pneumonia | 9 | 2022 | 636 | 0.660 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 7 | 2026 | 696 | 0.650 |
Why?
|
| Dendritic Cells | 1 | 2024 | 510 | 0.650 |
Why?
|
| Cellular Senescence | 5 | 2026 | 229 | 0.640 |
Why?
|
| Pulmonary Circulation | 13 | 2020 | 434 | 0.630 |
Why?
|
| Coronary Vessels | 4 | 2021 | 246 | 0.630 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 7 | 2012 | 61 | 0.630 |
Why?
|
| Caspase 3 | 11 | 2012 | 242 | 0.620 |
Why?
|
| Macrophages | 9 | 2025 | 1529 | 0.620 |
Why?
|
| Fatty Acids | 3 | 2022 | 461 | 0.590 |
Why?
|
| Pyrroles | 10 | 2020 | 221 | 0.580 |
Why?
|
| Vascular Diseases | 5 | 2026 | 252 | 0.560 |
Why?
|
| Male | 137 | 2026 | 73950 | 0.560 |
Why?
|
| Cell Division | 16 | 2003 | 758 | 0.560 |
Why?
|
| Cell Differentiation | 5 | 2018 | 2054 | 0.550 |
Why?
|
| Histological Techniques | 1 | 2018 | 39 | 0.530 |
Why?
|
| Ventricular Dysfunction, Right | 3 | 2018 | 248 | 0.520 |
Why?
|
| Pulmonary Fibrosis | 7 | 2023 | 395 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2026 | 241 | 0.520 |
Why?
|
| Cell Plasticity | 1 | 2018 | 37 | 0.520 |
Why?
|
| Receptors, Transforming Growth Factor beta | 4 | 2008 | 55 | 0.510 |
Why?
|
| Myofibroblasts | 3 | 2026 | 149 | 0.510 |
Why?
|
| Gene Expression Profiling | 18 | 2024 | 1794 | 0.510 |
Why?
|
| Macrophages, Alveolar | 8 | 2023 | 377 | 0.500 |
Why?
|
| PPAR gamma | 1 | 2018 | 182 | 0.500 |
Why?
|
| Glycocalyx | 2 | 2018 | 30 | 0.500 |
Why?
|
| Endothelium | 8 | 2015 | 119 | 0.500 |
Why?
|
| Indoles | 11 | 2020 | 510 | 0.500 |
Why?
|
| Cell Proliferation | 17 | 2020 | 2529 | 0.490 |
Why?
|
| Iron | 3 | 2018 | 361 | 0.490 |
Why?
|
| Female | 97 | 2026 | 80076 | 0.480 |
Why?
|
| NADPH Oxidases | 1 | 2017 | 123 | 0.480 |
Why?
|
| Granuloma | 5 | 2019 | 97 | 0.470 |
Why?
|
| Superoxide Dismutase | 5 | 2017 | 308 | 0.460 |
Why?
|
| Oxygen | 8 | 2011 | 998 | 0.460 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2021 | 437 | 0.450 |
Why?
|
| Gene Expression Regulation | 22 | 2020 | 2625 | 0.440 |
Why?
|
| Immunohistochemistry | 21 | 2021 | 1730 | 0.430 |
Why?
|
| Vasculitis | 6 | 1998 | 69 | 0.430 |
Why?
|
| Interleukin-13 | 3 | 2016 | 149 | 0.430 |
Why?
|
| Regeneration | 3 | 2014 | 198 | 0.430 |
Why?
|
| Phenotype | 16 | 2024 | 3216 | 0.430 |
Why?
|
| Heart Diseases | 4 | 2018 | 341 | 0.430 |
Why?
|
| Cells, Cultured | 30 | 2025 | 4169 | 0.420 |
Why?
|
| Neovascularization, Pathologic | 7 | 2013 | 287 | 0.420 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 567 | 0.410 |
Why?
|
| Sphingosine | 3 | 2019 | 47 | 0.410 |
Why?
|
| Vasoconstriction | 8 | 2020 | 216 | 0.400 |
Why?
|
| Mitochondria | 8 | 2023 | 1000 | 0.400 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2011 | 69 | 0.400 |
Why?
|
| Lipolysis | 1 | 2014 | 44 | 0.400 |
Why?
|
| Schistosoma | 5 | 2024 | 29 | 0.400 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2013 | 459 | 0.400 |
Why?
|
| Thrombospondin 1 | 4 | 2025 | 28 | 0.400 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2020 | 435 | 0.390 |
Why?
|
| Intramolecular Oxidoreductases | 5 | 2014 | 65 | 0.390 |
Why?
|
| Vascular Endothelial Growth Factors | 12 | 2002 | 78 | 0.390 |
Why?
|
| Caspase Inhibitors | 6 | 2011 | 81 | 0.380 |
Why?
|
| Endotoxemia | 2 | 2012 | 86 | 0.380 |
Why?
|
| Case-Control Studies | 19 | 2020 | 3660 | 0.370 |
Why?
|
| Neutrophils | 8 | 2014 | 1135 | 0.370 |
Why?
|
| Lactic Acid | 2 | 2023 | 295 | 0.370 |
Why?
|
| Hyperoxia | 3 | 2011 | 127 | 0.370 |
Why?
|
| Glucose | 2 | 2015 | 1051 | 0.370 |
Why?
|
| Transcriptome | 5 | 2024 | 1059 | 0.360 |
Why?
|
| Inflammation Mediators | 4 | 2018 | 507 | 0.360 |
Why?
|
| Middle Aged | 61 | 2025 | 36821 | 0.360 |
Why?
|
| Microsatellite Repeats | 3 | 2002 | 159 | 0.360 |
Why?
|
| Platelet Activation | 2 | 2024 | 99 | 0.360 |
Why?
|
| Monocytes | 4 | 2025 | 539 | 0.350 |
Why?
|
| Lung Diseases, Interstitial | 9 | 2013 | 675 | 0.350 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2026 | 1162 | 0.350 |
Why?
|
| Interleukin-6 | 4 | 2016 | 784 | 0.340 |
Why?
|
| Genes, bcl-2 | 1 | 2011 | 22 | 0.340 |
Why?
|
| Triglycerides | 1 | 2014 | 529 | 0.340 |
Why?
|
| Blood Platelets | 4 | 2024 | 381 | 0.340 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 566 | 0.340 |
Why?
|
| Mice, Transgenic | 16 | 2021 | 2197 | 0.330 |
Why?
|
| RNA, Messenger | 21 | 2019 | 2812 | 0.320 |
Why?
|
| Adult | 58 | 2025 | 41405 | 0.320 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 14 | 2010 | 751 | 0.320 |
Why?
|
| Mucous Membrane | 1 | 2011 | 130 | 0.320 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2008 | 106 | 0.310 |
Why?
|
| Hypertrophy | 6 | 2018 | 128 | 0.310 |
Why?
|
| Neovascularization, Physiologic | 4 | 2021 | 197 | 0.310 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2014 | 163 | 0.310 |
Why?
|
| Antioxidants | 9 | 2017 | 550 | 0.300 |
Why?
|
| Aging | 8 | 2024 | 1992 | 0.300 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2011 | 227 | 0.300 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2014 | 456 | 0.300 |
Why?
|
| Hemorrhage | 10 | 1998 | 832 | 0.300 |
Why?
|
| Bronchiolitis Obliterans | 4 | 2003 | 61 | 0.290 |
Why?
|
| ErbB Receptors | 2 | 2011 | 638 | 0.290 |
Why?
|
| Sphingolipids | 2 | 2008 | 83 | 0.290 |
Why?
|
| Eisenmenger Complex | 1 | 2009 | 13 | 0.290 |
Why?
|
| Enzyme Activation | 8 | 2013 | 762 | 0.290 |
Why?
|
| Metabolome | 2 | 2025 | 391 | 0.290 |
Why?
|
| Telomere | 5 | 2019 | 298 | 0.290 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2006 | 87 | 0.290 |
Why?
|
| Stress, Physiological | 2 | 2011 | 445 | 0.280 |
Why?
|
| Models, Biological | 10 | 2020 | 1772 | 0.280 |
Why?
|
| Multiprotein Complexes | 3 | 2014 | 172 | 0.280 |
Why?
|
| Simvastatin | 5 | 2007 | 59 | 0.280 |
Why?
|
| Lipopolysaccharides | 9 | 2023 | 863 | 0.270 |
Why?
|
| Cytomegalovirus | 3 | 1996 | 172 | 0.270 |
Why?
|
| Energy Metabolism | 4 | 2016 | 936 | 0.270 |
Why?
|
| Biomarkers | 17 | 2020 | 4351 | 0.270 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 1996 | 207 | 0.260 |
Why?
|
| Th2 Cells | 5 | 2026 | 179 | 0.260 |
Why?
|
| Organ Size | 8 | 2017 | 465 | 0.260 |
Why?
|
| Fibrinolysin | 1 | 2007 | 19 | 0.250 |
Why?
|
| RNA Viruses | 1 | 2008 | 73 | 0.250 |
Why?
|
| Complement System Proteins | 3 | 2025 | 320 | 0.250 |
Why?
|
| Tyrosine | 2 | 2005 | 218 | 0.250 |
Why?
|
| Epoprostenol | 2 | 2012 | 132 | 0.250 |
Why?
|
| Bone Marrow Cells | 5 | 2020 | 325 | 0.250 |
Why?
|
| Homeostasis | 4 | 2014 | 651 | 0.250 |
Why?
|
| Heart-Assist Devices | 3 | 2021 | 571 | 0.250 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2002 | 627 | 0.250 |
Why?
|
| Nitric Oxide | 8 | 2011 | 892 | 0.240 |
Why?
|
| Thrombin | 2 | 2007 | 174 | 0.240 |
Why?
|
| MicroRNAs | 3 | 2022 | 694 | 0.240 |
Why?
|
| Mannose-Binding Lectin | 1 | 2026 | 23 | 0.240 |
Why?
|
| HLA-DP beta-Chains | 2 | 2019 | 88 | 0.240 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2024 | 156 | 0.240 |
Why?
|
| Blotting, Western | 8 | 2013 | 1186 | 0.240 |
Why?
|
| Trypsin Inhibitors | 1 | 2006 | 7 | 0.240 |
Why?
|
| Lysophospholipids | 3 | 2019 | 80 | 0.240 |
Why?
|
| Cattle | 9 | 2025 | 948 | 0.240 |
Why?
|
| Cyclic AMP | 3 | 2000 | 208 | 0.230 |
Why?
|
| Laser Capture Microdissection | 2 | 2018 | 29 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2017 | 430 | 0.230 |
Why?
|
| Connective Tissue Diseases | 2 | 2025 | 85 | 0.230 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2020 | 239 | 0.230 |
Why?
|
| Oxidation-Reduction | 6 | 2017 | 1077 | 0.230 |
Why?
|
| Cytokines | 10 | 2023 | 2086 | 0.230 |
Why?
|
| Aspartic Acid | 2 | 2003 | 88 | 0.230 |
Why?
|
| Integrins | 1 | 2026 | 90 | 0.230 |
Why?
|
| Growth Differentiation Factor 15 | 2 | 2019 | 44 | 0.220 |
Why?
|
| Gene Deletion | 5 | 2019 | 392 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2008 | 2791 | 0.220 |
Why?
|
| Bronchoalveolar Lavage Fluid | 13 | 2019 | 641 | 0.220 |
Why?
|
| Phosphofructokinase-2 | 2 | 2022 | 16 | 0.220 |
Why?
|
| Bleomycin | 4 | 2021 | 256 | 0.220 |
Why?
|
| Capillaries | 7 | 2011 | 125 | 0.220 |
Why?
|
| Animals, Newborn | 9 | 2014 | 914 | 0.220 |
Why?
|
| Superoxides | 3 | 2017 | 199 | 0.210 |
Why?
|
| Sphingomyelin Phosphodiesterase | 4 | 2023 | 27 | 0.210 |
Why?
|
| Cyclins | 2 | 2003 | 79 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2014 | 980 | 0.200 |
Why?
|
| Severity of Illness Index | 10 | 2019 | 2973 | 0.200 |
Why?
|
| Gene Products, nef | 3 | 2009 | 12 | 0.200 |
Why?
|
| DNA Damage | 3 | 2018 | 440 | 0.200 |
Why?
|
| Flow Cytometry | 6 | 2018 | 1172 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 323 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 7 | 2014 | 365 | 0.190 |
Why?
|
| RNA, Small Interfering | 7 | 2018 | 643 | 0.190 |
Why?
|
| Appetite Depressants | 2 | 2004 | 19 | 0.190 |
Why?
|
| Glycolysis | 5 | 2025 | 341 | 0.190 |
Why?
|
| Lung Diseases, Obstructive | 2 | 2000 | 43 | 0.190 |
Why?
|
| Sirtuin 3 | 1 | 2023 | 60 | 0.190 |
Why?
|
| Proteomics | 3 | 2024 | 1203 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 8 | 2014 | 1266 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2013 | 1224 | 0.190 |
Why?
|
| Lung Neoplasms | 4 | 2011 | 2679 | 0.190 |
Why?
|
| Antibodies | 1 | 2005 | 398 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2013 | 1183 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2011 | 203 | 0.180 |
Why?
|
| Monocrotaline | 6 | 2022 | 34 | 0.180 |
Why?
|
| Hemodynamics | 5 | 2013 | 1127 | 0.180 |
Why?
|
| Schistosoma japonicum | 1 | 2022 | 36 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2020 | 57 | 0.170 |
Why?
|
| Disease Progression | 7 | 2021 | 2890 | 0.170 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2020 | 199 | 0.170 |
Why?
|
| Assisted Circulation | 1 | 2021 | 26 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2021 | 21 | 0.170 |
Why?
|
| Cell Line | 11 | 2017 | 2832 | 0.170 |
Why?
|
| Phosphorylation | 6 | 2024 | 1721 | 0.170 |
Why?
|
| Asthma | 6 | 2016 | 1805 | 0.170 |
Why?
|
| Research Report | 1 | 2022 | 89 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 3 | 2014 | 215 | 0.170 |
Why?
|
| Acetylcysteine | 4 | 2013 | 139 | 0.170 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2001 | 61 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2012 | 74 | 0.160 |
Why?
|
| Airway Remodeling | 2 | 2012 | 63 | 0.160 |
Why?
|
| Gene Expression | 9 | 2016 | 1481 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2015 | 2458 | 0.160 |
Why?
|
| Succinate Dehydrogenase | 1 | 2021 | 65 | 0.160 |
Why?
|
| Cytoprotection | 3 | 2016 | 56 | 0.160 |
Why?
|
| Complement Activation | 2 | 2024 | 401 | 0.160 |
Why?
|
| Nitric Oxide Synthase | 6 | 2005 | 234 | 0.160 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2020 | 6 | 0.160 |
Why?
|
| Endothelin-1 | 4 | 2013 | 181 | 0.160 |
Why?
|
| Smad3 Protein | 3 | 2024 | 42 | 0.160 |
Why?
|
| Smad2 Protein | 3 | 2024 | 37 | 0.160 |
Why?
|
| Cytomegalovirus Infections | 3 | 1994 | 210 | 0.160 |
Why?
|
| HIV Infections | 5 | 2014 | 3235 | 0.160 |
Why?
|
| Immunoenzyme Techniques | 4 | 2013 | 200 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2023 | 376 | 0.160 |
Why?
|
| Dogs | 5 | 2016 | 518 | 0.160 |
Why?
|
| Analysis of Variance | 3 | 2012 | 1302 | 0.160 |
Why?
|
| Ligands | 4 | 2023 | 675 | 0.160 |
Why?
|
| Aortic Diseases | 1 | 2021 | 126 | 0.160 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2020 | 19 | 0.150 |
Why?
|
| Aged | 22 | 2025 | 26514 | 0.150 |
Why?
|
| Golgi Apparatus | 2 | 2011 | 99 | 0.150 |
Why?
|
| Stem Cells | 3 | 2015 | 630 | 0.150 |
Why?
|
| Carrier Proteins | 6 | 2023 | 731 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 83 | 0.150 |
Why?
|
| Cell Survival | 4 | 2017 | 1111 | 0.150 |
Why?
|
| Tissue Banks | 2 | 2009 | 17 | 0.150 |
Why?
|
| Cell Hypoxia | 3 | 2016 | 249 | 0.150 |
Why?
|
| Respiratory Function Tests | 5 | 2019 | 545 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2010 | 264 | 0.150 |
Why?
|
| Arachidonate 5-Lipoxygenase | 4 | 2004 | 37 | 0.150 |
Why?
|
| Systems Analysis | 1 | 2019 | 23 | 0.150 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 196 | 0.150 |
Why?
|
| Isotope Labeling | 1 | 2020 | 82 | 0.150 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2019 | 49 | 0.150 |
Why?
|
| Collagen | 4 | 2012 | 460 | 0.150 |
Why?
|
| Calgranulin A | 1 | 2019 | 11 | 0.140 |
Why?
|
| Infant, Newborn | 5 | 2021 | 6543 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 2 | 2020 | 407 | 0.140 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 81 | 0.140 |
Why?
|
| Bacteriophages | 1 | 2020 | 110 | 0.140 |
Why?
|
| Chronic Disease | 11 | 2009 | 1844 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 8 | 0.140 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 33 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2007 | 448 | 0.140 |
Why?
|
| Cytoplasm | 2 | 2017 | 255 | 0.140 |
Why?
|
| Lymphocytes | 5 | 2019 | 378 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2014 | 415 | 0.140 |
Why?
|
| Mutation | 6 | 2014 | 4130 | 0.140 |
Why?
|
| Reperfusion Injury | 4 | 2009 | 294 | 0.140 |
Why?
|
| Sialoglycoproteins | 3 | 2003 | 157 | 0.140 |
Why?
|
| Protein Deglycase DJ-1 | 2 | 2016 | 15 | 0.140 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 1998 | 10 | 0.140 |
Why?
|
| Cell Adhesion | 5 | 2013 | 451 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2014 | 337 | 0.140 |
Why?
|
| Vasodilation | 3 | 2011 | 522 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 2 | 2020 | 212 | 0.130 |
Why?
|
| Free Radical Scavengers | 3 | 2013 | 82 | 0.130 |
Why?
|
| Ventilators, Mechanical | 3 | 2007 | 71 | 0.130 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 31 | 0.130 |
Why?
|
| Prostaglandins | 1 | 1997 | 94 | 0.130 |
Why?
|
| Actins | 4 | 2026 | 428 | 0.130 |
Why?
|
| Cell Cycle Proteins | 2 | 2014 | 633 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 1999 | 261 | 0.130 |
Why?
|
| Stress, Mechanical | 3 | 2010 | 494 | 0.130 |
Why?
|
| Biomedical Research | 3 | 2010 | 723 | 0.130 |
Why?
|
| Heterozygote | 3 | 2014 | 317 | 0.130 |
Why?
|
| Bone Marrow Transplantation | 3 | 2015 | 298 | 0.130 |
Why?
|
| NADPH Oxidase 4 | 1 | 2017 | 8 | 0.130 |
Why?
|
| Chromosome Deletion | 2 | 2015 | 127 | 0.130 |
Why?
|
| Methamphetamine | 1 | 2018 | 75 | 0.130 |
Why?
|
| Glutathione Disulfide | 1 | 2017 | 30 | 0.130 |
Why?
|
| Enzyme Inhibitors | 6 | 2013 | 822 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2018 | 153 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 231 | 0.120 |
Why?
|
| Caspases | 5 | 2006 | 233 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2017 | 269 | 0.120 |
Why?
|
| Mice, 129 Strain | 2 | 2013 | 85 | 0.120 |
Why?
|
| Research | 2 | 2018 | 434 | 0.120 |
Why?
|
| Cell Communication | 3 | 2013 | 329 | 0.120 |
Why?
|
| Arginine | 2 | 2016 | 265 | 0.120 |
Why?
|
| Capillary Permeability | 7 | 2018 | 132 | 0.120 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 344 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 187 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 222 | 0.120 |
Why?
|
| Congresses as Topic | 3 | 2015 | 226 | 0.120 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 901 | 0.120 |
Why?
|
| RNA Interference | 2 | 2016 | 477 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2017 | 1912 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2012 | 132 | 0.120 |
Why?
|
| Sex Distribution | 2 | 2018 | 390 | 0.120 |
Why?
|
| Ventricular Function, Right | 1 | 2018 | 300 | 0.110 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2007 | 107 | 0.110 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 397 | 0.110 |
Why?
|
| Polymyositis | 1 | 1995 | 13 | 0.110 |
Why?
|
| Umbilical Veins | 3 | 2011 | 58 | 0.110 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2015 | 22 | 0.110 |
Why?
|
| Smad8 Protein | 1 | 2015 | 3 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2015 | 15 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2014 | 536 | 0.110 |
Why?
|
| Fibrosis | 4 | 2023 | 568 | 0.110 |
Why?
|
| Sepharose | 2 | 1994 | 32 | 0.110 |
Why?
|
| Sarcoidosis, Pulmonary | 2 | 2009 | 100 | 0.110 |
Why?
|
| Blood Pressure | 9 | 2020 | 1785 | 0.110 |
Why?
|
| Mice, Inbred ICR | 2 | 2013 | 113 | 0.110 |
Why?
|
| Endotoxins | 4 | 2014 | 217 | 0.110 |
Why?
|
| Telomere Shortening | 1 | 2015 | 20 | 0.110 |
Why?
|
| Heart Failure | 2 | 2021 | 2334 | 0.110 |
Why?
|
| Lipoprotein Lipase | 1 | 2015 | 56 | 0.110 |
Why?
|
| Calpain | 2 | 2013 | 61 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 7 | 2014 | 1046 | 0.110 |
Why?
|
| Macaca | 3 | 2011 | 66 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2008 | 133 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2012 | 80 | 0.110 |
Why?
|
| Alphaproteobacteria | 1 | 2014 | 7 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 342 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2015 | 207 | 0.110 |
Why?
|
| NF-kappa B | 4 | 2010 | 676 | 0.110 |
Why?
|
| Computer Simulation | 1 | 1999 | 1018 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2012 | 56 | 0.110 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 48 | 0.110 |
Why?
|
| Receptors, CCR2 | 2 | 2025 | 39 | 0.110 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2014 | 40 | 0.110 |
Why?
|
| Frozen Sections | 1 | 1994 | 25 | 0.100 |
Why?
|
| Vascular Resistance | 2 | 2007 | 372 | 0.100 |
Why?
|
| Polycythemia | 2 | 2013 | 25 | 0.100 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 210 | 0.100 |
Why?
|
| Antigens, CD | 5 | 2020 | 562 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2010 | 383 | 0.100 |
Why?
|
| B-Lymphocytes | 2 | 2019 | 878 | 0.100 |
Why?
|
| Age Factors | 4 | 2024 | 3372 | 0.100 |
Why?
|
| Bronchiolitis | 3 | 2002 | 87 | 0.100 |
Why?
|
| Biological Transport | 1 | 2015 | 425 | 0.100 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2014 | 62 | 0.100 |
Why?
|
| Kidney Function Tests | 3 | 2011 | 156 | 0.100 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2013 | 15 | 0.100 |
Why?
|
| Transcription, Genetic | 6 | 2013 | 1456 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2022 | 984 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2012 | 522 | 0.100 |
Why?
|
| Tissue Engineering | 1 | 2018 | 439 | 0.100 |
Why?
|
| Gene Amplification | 1 | 1994 | 118 | 0.100 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 95 | 0.100 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1994 | 93 | 0.100 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1994 | 211 | 0.100 |
Why?
|
| Chromans | 1 | 2013 | 25 | 0.100 |
Why?
|
| Tunica Intima | 2 | 2004 | 79 | 0.100 |
Why?
|
| Adenoviridae | 3 | 2016 | 199 | 0.100 |
Why?
|
| Polymers | 2 | 2014 | 486 | 0.100 |
Why?
|
| Acute Kidney Injury | 3 | 2011 | 880 | 0.100 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2013 | 2 | 0.100 |
Why?
|
| Diagnosis, Differential | 7 | 2005 | 1518 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2014 | 181 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 891 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2019 | 1504 | 0.090 |
Why?
|
| Fetus | 5 | 1999 | 805 | 0.090 |
Why?
|
| Endopeptidases | 2 | 2003 | 80 | 0.090 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2011 | 93 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 210 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 538 | 0.090 |
Why?
|
| Glucuronidase | 1 | 2012 | 27 | 0.090 |
Why?
|
| Gap Junctions | 1 | 2013 | 68 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 536 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 288 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2005 | 398 | 0.090 |
Why?
|
| Vulvar Neoplasms | 1 | 1992 | 13 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 1996 | 481 | 0.090 |
Why?
|
| Alveolitis, Extrinsic Allergic | 2 | 2004 | 96 | 0.090 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 73 | 0.090 |
Why?
|
| Intestinal Perforation | 1 | 2012 | 46 | 0.090 |
Why?
|
| Cell Count | 3 | 2020 | 321 | 0.090 |
Why?
|
| Lymphatic Vessels | 1 | 2012 | 63 | 0.090 |
Why?
|
| Chemokines | 2 | 2019 | 217 | 0.090 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 200 | 0.090 |
Why?
|
| Membrane Proteins | 4 | 2009 | 1171 | 0.090 |
Why?
|
| Berylliosis | 1 | 2014 | 204 | 0.090 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2011 | 39 | 0.090 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2012 | 61 | 0.090 |
Why?
|
| Telomerase | 2 | 2011 | 250 | 0.090 |
Why?
|
| Lung Transplantation | 3 | 2003 | 338 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2002 | 53 | 0.090 |
Why?
|
| Complement C3 | 2 | 2025 | 188 | 0.090 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1992 | 76 | 0.080 |
Why?
|
| Autoimmune Diseases | 2 | 2006 | 471 | 0.080 |
Why?
|
| Snail Family Transcription Factors | 1 | 2011 | 18 | 0.080 |
Why?
|
| Aldehydes | 3 | 2019 | 140 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 615 | 0.080 |
Why?
|
| Reference Values | 6 | 2018 | 800 | 0.080 |
Why?
|
| Caveolae | 1 | 2011 | 16 | 0.080 |
Why?
|
| Estrogens | 1 | 2014 | 368 | 0.080 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 406 | 0.080 |
Why?
|
| In Situ Hybridization | 3 | 2001 | 318 | 0.080 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2011 | 23 | 0.080 |
Why?
|
| Lung Diseases, Parasitic | 1 | 2011 | 2 | 0.080 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2011 | 72 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 189 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2012 | 145 | 0.080 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1992 | 124 | 0.080 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 79 | 0.080 |
Why?
|
| Peptides | 4 | 2015 | 1003 | 0.080 |
Why?
|
| Heart Defects, Congenital | 2 | 2015 | 941 | 0.080 |
Why?
|
| Interferon-gamma | 4 | 2014 | 786 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2023 | 481 | 0.080 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 2 | 2011 | 4 | 0.080 |
Why?
|
| Risk Factors | 6 | 2015 | 11017 | 0.080 |
Why?
|
| Vascular Stiffness | 1 | 2015 | 488 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2011 | 133 | 0.080 |
Why?
|
| DNA Fragmentation | 2 | 2008 | 43 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 2030 | 0.080 |
Why?
|
| Lymphomatoid Granulomatosis | 2 | 2000 | 5 | 0.080 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 330 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2001 | 414 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 452 | 0.080 |
Why?
|
| Serum Amyloid A Protein | 1 | 2009 | 32 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2008 | 590 | 0.080 |
Why?
|
| Arteritis | 2 | 1986 | 23 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2008 | 144 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2023 | 373 | 0.070 |
Why?
|
| Neuropilin-1 | 1 | 2009 | 8 | 0.070 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 387 | 0.070 |
Why?
|
| Adolescent | 10 | 2020 | 22825 | 0.070 |
Why?
|
| Quinazolines | 1 | 2011 | 266 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 84 | 0.070 |
Why?
|
| Serine C-Palmitoyltransferase | 2 | 2008 | 8 | 0.070 |
Why?
|
| Heme Oxygenase-1 | 2 | 2013 | 76 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2020 | 161 | 0.070 |
Why?
|
| Peptide Library | 1 | 2009 | 91 | 0.070 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2007 | 117 | 0.070 |
Why?
|
| Oleanolic Acid | 1 | 2008 | 9 | 0.070 |
Why?
|
| Epithelium | 4 | 2017 | 311 | 0.070 |
Why?
|
| Biopsy | 7 | 2012 | 1093 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 334 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 125 | 0.070 |
Why?
|
| beta Catenin | 1 | 2011 | 254 | 0.070 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2008 | 14 | 0.070 |
Why?
|
| Arteries | 2 | 2004 | 262 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 158 | 0.070 |
Why?
|
| Cell Separation | 3 | 2016 | 306 | 0.070 |
Why?
|
| Xanthine Dehydrogenase | 1 | 2008 | 24 | 0.070 |
Why?
|
| Graft Rejection | 4 | 2003 | 523 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 156 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 268 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 1987 | 865 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2011 | 49 | 0.070 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2008 | 13 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 38 | 0.070 |
Why?
|
| Chemokine CXCL12 | 2 | 2020 | 86 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor C | 2 | 2022 | 16 | 0.070 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 318 | 0.070 |
Why?
|
| Hydrochloric Acid | 1 | 2008 | 9 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 3448 | 0.070 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 82 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 445 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 62 | 0.070 |
Why?
|
| Clone Cells | 2 | 1998 | 263 | 0.070 |
Why?
|
| Muscle, Smooth | 2 | 1999 | 153 | 0.070 |
Why?
|
| Transcriptional Activation | 4 | 2013 | 372 | 0.070 |
Why?
|
| Histidine-tRNA Ligase | 1 | 2007 | 1 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2020 | 177 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 5 | 2009 | 120 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2014 | 524 | 0.070 |
Why?
|
| Hemangioma | 1 | 1987 | 46 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 440 | 0.060 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2007 | 12 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2018 | 6099 | 0.060 |
Why?
|
| Morphogenesis | 1 | 2008 | 171 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2009 | 269 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 451 | 0.060 |
Why?
|
| Lysosomes | 1 | 2007 | 133 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 421 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 1998 | 149 | 0.060 |
Why?
|
| B7-1 Antigen | 1 | 2007 | 55 | 0.060 |
Why?
|
| Myositis | 1 | 2007 | 57 | 0.060 |
Why?
|
| Inhalation Exposure | 1 | 2007 | 103 | 0.060 |
Why?
|
| Global Health | 1 | 2010 | 406 | 0.060 |
Why?
|
| Necrosis | 1 | 2008 | 245 | 0.060 |
Why?
|
| Base Sequence | 4 | 2007 | 2175 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2006 | 6 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 2007 | 155 | 0.060 |
Why?
|
| Cell-Free System | 1 | 2006 | 54 | 0.060 |
Why?
|
| Heart Neoplasms | 1 | 1987 | 56 | 0.060 |
Why?
|
| Interleukin-10 | 3 | 2022 | 311 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2008 | 224 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 1998 | 1049 | 0.060 |
Why?
|
| Acyltransferases | 2 | 2005 | 78 | 0.060 |
Why?
|
| Pleural Diseases | 1 | 1986 | 23 | 0.060 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2006 | 27 | 0.060 |
Why?
|
| Complement C4 | 1 | 2026 | 31 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2009 | 324 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 1986 | 31 | 0.060 |
Why?
|
| Mycobacterium Infections | 1 | 1986 | 55 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 187 | 0.060 |
Why?
|
| Gene Knockout Techniques | 2 | 2020 | 122 | 0.060 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2006 | 24 | 0.060 |
Why?
|
| Fetal Distress | 1 | 2006 | 14 | 0.060 |
Why?
|
| STAT6 Transcription Factor | 2 | 2016 | 24 | 0.060 |
Why?
|
| Paracoccidioidomycosis | 1 | 1985 | 2 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2008 | 191 | 0.060 |
Why?
|
| Metabolomics | 2 | 2025 | 736 | 0.060 |
Why?
|
| Xanthine Oxidase | 1 | 2006 | 79 | 0.060 |
Why?
|
| Lung Diseases, Fungal | 1 | 1985 | 12 | 0.060 |
Why?
|
| Virus Diseases | 1 | 2008 | 218 | 0.060 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 95 | 0.060 |
Why?
|
| Child | 5 | 2019 | 22979 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2018 | 8164 | 0.060 |
Why?
|
| Beryllium | 2 | 2019 | 163 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2005 | 90 | 0.060 |
Why?
|
| Survival Rate | 3 | 2009 | 2110 | 0.060 |
Why?
|
| Nephrectomy | 1 | 2007 | 172 | 0.060 |
Why?
|
| Perfusion | 2 | 2004 | 252 | 0.060 |
Why?
|
| Adaptive Immunity | 2 | 2019 | 171 | 0.060 |
Why?
|
| Fumonisins | 1 | 2005 | 3 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2026 | 54 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 889 | 0.060 |
Why?
|
| Kidney Diseases | 2 | 2007 | 428 | 0.060 |
Why?
|
| Carcinoma | 1 | 1987 | 231 | 0.060 |
Why?
|
| Virus Replication | 3 | 2006 | 521 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 174 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 14437 | 0.060 |
Why?
|
| Interleukin-1 | 4 | 1998 | 961 | 0.060 |
Why?
|
| Acute Disease | 6 | 2007 | 1049 | 0.060 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2005 | 55 | 0.050 |
Why?
|
| Mucormycosis | 1 | 1985 | 18 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 222 | 0.050 |
Why?
|
| Drug Combinations | 2 | 2004 | 399 | 0.050 |
Why?
|
| Factor VIII | 2 | 1997 | 107 | 0.050 |
Why?
|
| Skin | 1 | 1990 | 759 | 0.050 |
Why?
|
| Deoxyguanosine | 1 | 2004 | 25 | 0.050 |
Why?
|
| rho-Associated Kinases | 2 | 2020 | 82 | 0.050 |
Why?
|
| Mitomycin | 1 | 2024 | 33 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2005 | 91 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2005 | 227 | 0.050 |
Why?
|
| eIF-2 Kinase | 1 | 2024 | 28 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2024 | 32 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2025 | 112 | 0.050 |
Why?
|
| Protein Phosphatase 1 | 1 | 2024 | 32 | 0.050 |
Why?
|
| Complement C5a | 1 | 2024 | 54 | 0.050 |
Why?
|
| Complement C3a | 1 | 2024 | 40 | 0.050 |
Why?
|
| Kinetics | 1 | 2008 | 1569 | 0.050 |
Why?
|
| Kidney | 3 | 2011 | 1511 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2005 | 249 | 0.050 |
Why?
|
| Transfection | 4 | 2008 | 930 | 0.050 |
Why?
|
| Carcinoma, Basosquamous | 1 | 1984 | 2 | 0.050 |
Why?
|
| Organ Specificity | 3 | 2013 | 310 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2005 | 333 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2007 | 499 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2025 | 98 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 597 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 308 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1987 | 261 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 1984 | 25 | 0.050 |
Why?
|
| Coronary Disease | 1 | 1986 | 382 | 0.050 |
Why?
|
| Cell Death | 2 | 2007 | 383 | 0.050 |
Why?
|
| Bronchi | 4 | 2000 | 263 | 0.050 |
Why?
|
| Phentermine | 1 | 2004 | 14 | 0.050 |
Why?
|
| Antigens, Viral | 2 | 1996 | 186 | 0.050 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 616 | 0.050 |
Why?
|
| Mice, Inbred Strains | 3 | 2011 | 397 | 0.050 |
Why?
|
| Fenfluramine | 1 | 2004 | 20 | 0.050 |
Why?
|
| Guanosine | 1 | 2003 | 40 | 0.050 |
Why?
|
| HIV-1 | 2 | 2009 | 917 | 0.050 |
Why?
|
| Allyl Compounds | 1 | 2023 | 25 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 1 | 2004 | 57 | 0.050 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2026 | 293 | 0.050 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2014 | 138 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 1 | 1984 | 173 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2019 | 12016 | 0.050 |
Why?
|
| Biphenyl Compounds | 1 | 2023 | 67 | 0.050 |
Why?
|
| Prednisone | 2 | 1996 | 230 | 0.050 |
Why?
|
| Herpesvirus 8, Human | 1 | 2003 | 67 | 0.050 |
Why?
|
| Spirometry | 2 | 2002 | 235 | 0.050 |
Why?
|
| Biopsy, Needle | 2 | 2018 | 186 | 0.050 |
Why?
|
| NAD | 1 | 2023 | 79 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2001 | 398 | 0.050 |
Why?
|
| Cell Membrane | 3 | 2013 | 711 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2003 | 36 | 0.050 |
Why?
|
| Phenols | 1 | 2023 | 106 | 0.050 |
Why?
|
| Tunica Media | 1 | 2002 | 38 | 0.050 |
Why?
|
| DNA | 2 | 2001 | 1444 | 0.050 |
Why?
|
| Methylprednisolone | 1 | 2003 | 59 | 0.050 |
Why?
|
| Imatinib Mesylate | 1 | 2022 | 77 | 0.050 |
Why?
|
| beta 2-Microglobulin | 2 | 1994 | 48 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2025 | 368 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Bradykinin Receptor Antagonists | 1 | 2002 | 3 | 0.050 |
Why?
|
| Ischemia | 1 | 2005 | 424 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 3565 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2002 | 10 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2008 | 840 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 2003 | 148 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2002 | 12 | 0.040 |
Why?
|
| Receptors, Epoprostenol | 1 | 2002 | 5 | 0.040 |
Why?
|
| Indomethacin | 1 | 1982 | 77 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2002 | 32 | 0.040 |
Why?
|
| Receptors, Prostaglandin | 1 | 2002 | 21 | 0.040 |
Why?
|
| United States | 6 | 2020 | 16313 | 0.040 |
Why?
|
| Resuscitation | 2 | 1995 | 318 | 0.040 |
Why?
|
| Oxidants | 2 | 2009 | 99 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 1496 | 0.040 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.040 |
Why?
|
| Erythropoietin | 2 | 2013 | 100 | 0.040 |
Why?
|
| ADAMTS4 Protein | 1 | 2021 | 16 | 0.040 |
Why?
|
| Long Term Adverse Effects | 1 | 2021 | 13 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 1195 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 369 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2018 | 618 | 0.040 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2001 | 19 | 0.040 |
Why?
|
| Hemoptysis | 2 | 1998 | 35 | 0.040 |
Why?
|
| Anaerobiosis | 1 | 2021 | 65 | 0.040 |
Why?
|
| Growth Substances | 2 | 2004 | 138 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2016 | 162 | 0.040 |
Why?
|
| Hematologic Diseases | 1 | 2001 | 66 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 264 | 0.040 |
Why?
|
| Jurkat Cells | 2 | 2012 | 115 | 0.040 |
Why?
|
| Heart Transplantation | 2 | 1992 | 682 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2025 | 572 | 0.040 |
Why?
|
| Immunity | 2 | 2015 | 141 | 0.040 |
Why?
|
| Pancreatitis | 1 | 1982 | 147 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 2001 | 50 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 114 | 0.040 |
Why?
|
| Prognosis | 3 | 2020 | 4383 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 2020 | 40 | 0.040 |
Why?
|
| Parabiosis | 1 | 2020 | 11 | 0.040 |
Why?
|
| Time Factors | 7 | 2008 | 7173 | 0.040 |
Why?
|
| Deferoxamine | 1 | 2020 | 27 | 0.040 |
Why?
|
| Iron Chelating Agents | 1 | 2020 | 17 | 0.040 |
Why?
|
| Platelet Factor 4 | 1 | 2020 | 36 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2020 | 33 | 0.040 |
Why?
|
| Caspase 7 | 2 | 2012 | 22 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2007 | 932 | 0.040 |
Why?
|
| Autoantibodies | 2 | 2006 | 1513 | 0.040 |
Why?
|
| Leukosialin | 1 | 2020 | 12 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Sheep | 4 | 1997 | 879 | 0.040 |
Why?
|
| Optical Devices | 1 | 2020 | 13 | 0.040 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2014 | 90 | 0.040 |
Why?
|
| Staining and Labeling | 3 | 1997 | 153 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 61 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2020 | 10 | 0.040 |
Why?
|
| Pericytes | 1 | 2020 | 42 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2006 | 935 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 93 | 0.040 |
Why?
|
| Complement C5 | 1 | 2020 | 33 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1997 | 203 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 58 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 133 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2020 | 55 | 0.040 |
Why?
|
| Proteins | 1 | 2006 | 1024 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2001 | 267 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1995 | 237 | 0.040 |
Why?
|
| CREST Syndrome | 1 | 1999 | 6 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2001 | 680 | 0.040 |
Why?
|
| Tertiary Lymphoid Structures | 1 | 2019 | 7 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2001 | 274 | 0.040 |
Why?
|
| Cryptogenic Organizing Pneumonia | 2 | 1999 | 20 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1999 | 64 | 0.040 |
Why?
|
| Chemokine CXCL13 | 1 | 2019 | 15 | 0.040 |
Why?
|
| Mycoplasma Infections | 1 | 1999 | 17 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2019 | 55 | 0.040 |
Why?
|
| Myocardium | 2 | 2004 | 947 | 0.040 |
Why?
|
| Microvessels | 1 | 2020 | 98 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2020 | 163 | 0.040 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2020 | 70 | 0.040 |
Why?
|
| Heart | 2 | 2020 | 628 | 0.040 |
Why?
|
| Haplotypes | 2 | 2014 | 509 | 0.040 |
Why?
|
| Tissue Donors | 2 | 2020 | 427 | 0.040 |
Why?
|
| Dexfenfluramine | 1 | 1998 | 1 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 443 | 0.040 |
Why?
|
| Aminorex | 1 | 1998 | 2 | 0.040 |
Why?
|
| Complement Factor B | 1 | 2020 | 106 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 2 | 1999 | 93 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 2012 | 1514 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 75 | 0.040 |
Why?
|
| Fibrillins | 2 | 2009 | 9 | 0.040 |
Why?
|
| Fibrillin-1 | 2 | 2009 | 6 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 1999 | 85 | 0.040 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2011 | 19 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 246 | 0.040 |
Why?
|
| Complement Pathway, Alternative | 1 | 2020 | 121 | 0.040 |
Why?
|
| Syndecans | 1 | 2018 | 5 | 0.040 |
Why?
|
| Cell Movement | 3 | 2013 | 966 | 0.040 |
Why?
|
| Mycoplasma pneumoniae | 1 | 1999 | 54 | 0.040 |
Why?
|
| X Chromosome | 1 | 1998 | 66 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2019 | 1386 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 207 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 1998 | 23 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2000 | 253 | 0.030 |
Why?
|
| CD13 Antigens | 1 | 1998 | 11 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1998 | 45 | 0.030 |
Why?
|
| Adipokines | 2 | 2009 | 57 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 2018 | 67 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 2012 | 616 | 0.030 |
Why?
|
| fas Receptor | 1 | 2018 | 91 | 0.030 |
Why?
|
| Germ-Line Mutation | 2 | 2010 | 180 | 0.030 |
Why?
|
| Doxycycline | 2 | 2012 | 62 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 2014 | 112 | 0.030 |
Why?
|
| Adenylyl Cyclases | 1 | 1998 | 60 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2010 | 330 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 119 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2000 | 794 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1999 | 197 | 0.030 |
Why?
|
| Endothelins | 1 | 1998 | 61 | 0.030 |
Why?
|
| Microarray Analysis | 2 | 2010 | 117 | 0.030 |
Why?
|
| Neprilysin | 1 | 1998 | 47 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 1998 | 99 | 0.030 |
Why?
|
| Microfilament Proteins | 2 | 2009 | 135 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 1998 | 61 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 5476 | 0.030 |
Why?
|
| Tretinoin | 1 | 1998 | 125 | 0.030 |
Why?
|
| Creatinine | 2 | 2011 | 516 | 0.030 |
Why?
|
| Calcium | 3 | 1998 | 1197 | 0.030 |
Why?
|
| Causality | 1 | 2018 | 129 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1998 | 177 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 839 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1998 | 134 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 103 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2018 | 63 | 0.030 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2009 | 94 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2017 | 46 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 288 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 1984 | 787 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 196 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 2009 | 338 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 587 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 780 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 1985 | 1213 | 0.030 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 1997 | 61 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 125 | 0.030 |
Why?
|
| Suramin | 1 | 1996 | 8 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 1997 | 87 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 1999 | 289 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2017 | 91 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 170 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1997 | 66 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2003 | 3022 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2014 | 337 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2009 | 1371 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 1997 | 120 | 0.030 |
Why?
|
| CD3 Complex | 1 | 1997 | 113 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 1994 | 253 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1996 | 34 | 0.030 |
Why?
|
| California | 1 | 2018 | 477 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 849 | 0.030 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1996 | 39 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 42 | 0.030 |
Why?
|
| Polyarteritis Nodosa | 1 | 1996 | 11 | 0.030 |
Why?
|
| Angiography | 3 | 2002 | 209 | 0.030 |
Why?
|
| Obesity | 2 | 2014 | 3149 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1998 | 318 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1996 | 53 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1996 | 46 | 0.030 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2015 | 9 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 2 | 2011 | 765 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2010 | 2223 | 0.030 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2016 | 104 | 0.030 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1996 | 36 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1995 | 99 | 0.030 |
Why?
|
| Activation, Metabolic | 1 | 2015 | 5 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 123 | 0.030 |
Why?
|
| Alleles | 1 | 1998 | 909 | 0.030 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2015 | 8 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2016 | 269 | 0.030 |
Why?
|
| Interferon-beta | 1 | 1996 | 92 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1995 | 12 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 375 | 0.030 |
Why?
|
| Phosphatidic Acids | 1 | 1995 | 8 | 0.030 |
Why?
|
| Retrospective Studies | 7 | 2015 | 17560 | 0.030 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 378 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 1997 | 194 | 0.030 |
Why?
|
| P-Selectin | 1 | 1995 | 29 | 0.030 |
Why?
|
| Mast Cells | 1 | 1996 | 148 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 19 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 45 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2015 | 139 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1994 | 43 | 0.030 |
Why?
|
| Proteolipids | 1 | 1994 | 28 | 0.030 |
Why?
|
| Physical Exertion | 1 | 1996 | 205 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2015 | 67 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2015 | 103 | 0.030 |
Why?
|
| Fixatives | 1 | 1994 | 13 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 123 | 0.030 |
Why?
|
| Infant | 2 | 2019 | 10194 | 0.030 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2014 | 12 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2014 | 35 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1997 | 242 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 1996 | 201 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 182 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2014 | 12 | 0.030 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2014 | 40 | 0.030 |
Why?
|
| Wound Healing | 1 | 2017 | 361 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2014 | 33 | 0.030 |
Why?
|
| HLA-A3 Antigen | 1 | 1994 | 6 | 0.030 |
Why?
|
| Mesoderm | 1 | 2015 | 147 | 0.030 |
Why?
|
| HLA-B7 Antigen | 1 | 1994 | 7 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 82 | 0.030 |
Why?
|
| Formaldehyde | 1 | 1994 | 65 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 626 | 0.030 |
Why?
|
| Dehydroepiandrosterone | 1 | 2014 | 49 | 0.030 |
Why?
|
| HLA-A2 Antigen | 1 | 1994 | 36 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2013 | 27 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 708 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2018 | 914 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 296 | 0.030 |
Why?
|
| Pulmonary Surfactants | 1 | 1994 | 105 | 0.020 |
Why?
|
| Blood Preservation | 1 | 1998 | 346 | 0.020 |
Why?
|
| Interleukins | 1 | 1995 | 248 | 0.020 |
Why?
|
| Vimentin | 1 | 1994 | 54 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1994 | 180 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1994 | 417 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2014 | 119 | 0.020 |
Why?
|
| Virus Shedding | 1 | 1994 | 53 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2013 | 62 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2013 | 50 | 0.020 |
Why?
|
| Mortality, Premature | 1 | 2013 | 15 | 0.020 |
Why?
|
| ADAM17 Protein | 1 | 2013 | 42 | 0.020 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1995 | 138 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2019 | 799 | 0.020 |
Why?
|
| Hypertension, Portal | 1 | 2014 | 67 | 0.020 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2013 | 14 | 0.020 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2013 | 5 | 0.020 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2013 | 3 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2013 | 65 | 0.020 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 9 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 1253 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2013 | 75 | 0.020 |
Why?
|
| Food | 1 | 2014 | 150 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 347 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2012 | 13 | 0.020 |
Why?
|
| Phospholipids | 1 | 1994 | 214 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 49 | 0.020 |
Why?
|
| Blood Vessels | 2 | 2000 | 167 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 1672 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2014 | 440 | 0.020 |
Why?
|
| Exercise | 1 | 2025 | 2219 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2012 | 27 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 163 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 173 | 0.020 |
Why?
|
| Lung Compliance | 1 | 2012 | 42 | 0.020 |
Why?
|
| Lipid Peroxidation | 2 | 2008 | 169 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 267 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 173 | 0.020 |
Why?
|
| Caspase 6 | 1 | 2012 | 3 | 0.020 |
Why?
|
| Physical Examination | 1 | 2014 | 245 | 0.020 |
Why?
|
| Genome, Human | 1 | 2015 | 426 | 0.020 |
Why?
|
| Kidney Transplantation | 2 | 2005 | 732 | 0.020 |
Why?
|
| Vulva | 1 | 1992 | 24 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2005 | 273 | 0.020 |
Why?
|
| Respiration, Artificial | 2 | 2008 | 717 | 0.020 |
Why?
|
| Isoantigens | 1 | 1992 | 17 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2011 | 35 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 25 | 0.020 |
Why?
|
| Spleen | 1 | 2014 | 509 | 0.020 |
Why?
|
| Losartan | 1 | 2011 | 13 | 0.020 |
Why?
|
| Administration, Inhalation | 2 | 2008 | 572 | 0.020 |
Why?
|
| Vaccination | 1 | 2020 | 1443 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 170 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2013 | 165 | 0.020 |
Why?
|
| Pulmonary Edema | 2 | 2005 | 105 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2011 | 39 | 0.020 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 525 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2011 | 42 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 546 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1720 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2013 | 139 | 0.020 |
Why?
|
| Dipeptides | 1 | 2011 | 56 | 0.020 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2011 | 6 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2011 | 85 | 0.020 |
Why?
|
| Arterioles | 1 | 2011 | 52 | 0.020 |
Why?
|
| Netrin-1 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Protein Binding | 2 | 2008 | 2249 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 369 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 75 | 0.020 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2011 | 3 | 0.020 |
Why?
|
| Longevity | 1 | 2013 | 178 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2011 | 85 | 0.020 |
Why?
|
| Glutathione | 2 | 2008 | 370 | 0.020 |
Why?
|
| Bronchioles | 1 | 2011 | 29 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 394 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 34 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 162 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 90 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 72 | 0.020 |
Why?
|
| Ceramidases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 342 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1994 | 385 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2011 | 145 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 290 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 975 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2010 | 25 | 0.020 |
Why?
|
| Bucladesine | 1 | 1990 | 19 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 1998 | 2231 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1990 | 24 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1994 | 537 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 862 | 0.020 |
Why?
|
| Testosterone | 1 | 2014 | 417 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 365 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2010 | 68 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 17 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 212 | 0.020 |
Why?
|
| Echocardiography | 1 | 2013 | 652 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 168 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 332 | 0.020 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2009 | 18 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 2003 | 422 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2009 | 89 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 156 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 190 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2009 | 24 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2004 | 335 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2009 | 48 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 698 | 0.020 |
Why?
|
| Intestines | 1 | 1992 | 356 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2008 | 9 | 0.020 |
Why?
|
| Endocytosis | 1 | 1990 | 168 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 303 | 0.020 |
Why?
|
| Peroxidase | 2 | 2004 | 168 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2009 | 188 | 0.020 |
Why?
|
| RNA | 2 | 2008 | 916 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 136 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2008 | 29 | 0.020 |
Why?
|
| Microtubules | 1 | 2011 | 267 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2009 | 114 | 0.020 |
Why?
|
| Integrases | 1 | 2009 | 122 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 366 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2008 | 37 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 86 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 345 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 669 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 172 | 0.020 |
Why?
|
| Diuresis | 1 | 2008 | 10 | 0.020 |
Why?
|
| Respiratory System | 1 | 2009 | 150 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 192 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2008 | 20 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2008 | 88 | 0.020 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2007 | 12 | 0.020 |
Why?
|
| Basement Membrane | 1 | 1987 | 32 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 2136 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2007 | 20 | 0.020 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2008 | 55 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2008 | 90 | 0.020 |
Why?
|
| Aorta | 1 | 2011 | 443 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2007 | 52 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 2954 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 77 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 2889 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2007 | 53 | 0.020 |
Why?
|
| Imidazoles | 1 | 2008 | 247 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2000 | 11947 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2008 | 179 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2007 | 62 | 0.020 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2007 | 33 | 0.020 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 2 | 1998 | 4 | 0.020 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2007 | 14 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2004 | 499 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2007 | 95 | 0.020 |
Why?
|
| Self Tolerance | 1 | 2007 | 26 | 0.020 |
Why?
|
| Granzymes | 1 | 2007 | 50 | 0.020 |
Why?
|
| Uremia | 1 | 2007 | 15 | 0.020 |
Why?
|
| Autopsy | 1 | 1987 | 96 | 0.020 |
Why?
|
| Microbiota | 1 | 2014 | 736 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2007 | 84 | 0.020 |
Why?
|
| Sample Size | 1 | 2007 | 124 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2004 | 840 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 372 | 0.010 |
Why?
|
| Metalloproteases | 1 | 2006 | 42 | 0.010 |
Why?
|
| Interferons | 1 | 2007 | 186 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1999 | 323 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2007 | 179 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2008 | 228 | 0.010 |
Why?
|
| Protein Transport | 1 | 2007 | 442 | 0.010 |
Why?
|
| Models, Animal | 1 | 2008 | 394 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2007 | 154 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 505 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2008 | 358 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2005 | 89 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 2005 | 25 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2007 | 502 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2005 | 33 | 0.010 |
Why?
|
| Histones | 1 | 2011 | 672 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 2470 | 0.010 |
Why?
|
| Cardiomegaly | 2 | 1997 | 175 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 381 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 547 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2005 | 194 | 0.010 |
Why?
|
| Diet | 1 | 2013 | 1284 | 0.010 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2004 | 26 | 0.010 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2007 | 268 | 0.010 |
Why?
|
| B7-H1 Antigen | 1 | 2007 | 246 | 0.010 |
Why?
|
| Pancreatic Elastase | 1 | 2004 | 54 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 2017 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 500 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 100 | 0.010 |
Why?
|
| Propylene Glycols | 1 | 2004 | 28 | 0.010 |
Why?
|
| Heart Septum | 1 | 2004 | 27 | 0.010 |
Why?
|
| Autoantigens | 1 | 2007 | 429 | 0.010 |
Why?
|
| Binding Sites | 1 | 2007 | 1319 | 0.010 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2004 | 40 | 0.010 |
Why?
|
| CD36 Antigens | 1 | 2003 | 32 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 1798 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 2003 | 42 | 0.010 |
Why?
|
| Blood Circulation | 1 | 2003 | 44 | 0.010 |
Why?
|
| Genes, Viral | 1 | 2003 | 88 | 0.010 |
Why?
|
| E-Selectin | 1 | 2003 | 61 | 0.010 |
Why?
|
| Family | 1 | 2008 | 690 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2007 | 695 | 0.010 |
Why?
|
| Potassium Channels | 1 | 2004 | 148 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 190 | 0.010 |
Why?
|
| Veins | 1 | 2003 | 69 | 0.010 |
Why?
|
| Thrombophilia | 1 | 2004 | 89 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 430 | 0.010 |
Why?
|
| Blood | 1 | 2003 | 107 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 409 | 0.010 |
Why?
|
| Insulin | 1 | 2014 | 2526 | 0.010 |
Why?
|
| Osteopontin | 1 | 2003 | 37 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 355 | 0.010 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2003 | 27 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1985 | 514 | 0.010 |
Why?
|
| Amylases | 1 | 1982 | 18 | 0.010 |
Why?
|
| Fat Necrosis | 1 | 1982 | 12 | 0.010 |
Why?
|
| Receptors, Bradykinin | 1 | 2002 | 5 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 391 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 189 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2003 | 325 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2003 | 357 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 48 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 2000 | 14 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 353 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2000 | 26 | 0.010 |
Why?
|
| Laminin | 1 | 2000 | 73 | 0.010 |
Why?
|
| Cyclohexanes | 1 | 2000 | 22 | 0.010 |
Why?
|
| Colorado | 1 | 2011 | 4591 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 1344 | 0.010 |
Why?
|
| Sesquiterpenes | 1 | 2000 | 52 | 0.010 |
Why?
|
| Multigene Family | 1 | 2001 | 210 | 0.010 |
Why?
|
| Thalidomide | 1 | 2000 | 43 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2000 | 112 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2000 | 104 | 0.010 |
Why?
|
| Gelatin | 1 | 2000 | 56 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2000 | 97 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2017 | 0.010 |
Why?
|
| Birth Weight | 1 | 2002 | 522 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2133 | 0.010 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1998 | 8 | 0.010 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 1998 | 6 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 1875 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 1998 | 34 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1998 | 22 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1998 | 83 | 0.010 |
Why?
|
| Mibefradil | 1 | 1998 | 9 | 0.010 |
Why?
|
| Neoplasms | 1 | 2014 | 2946 | 0.010 |
Why?
|
| Methicillin Resistance | 1 | 1998 | 17 | 0.010 |
Why?
|
| Calcitriol | 1 | 1998 | 59 | 0.010 |
Why?
|
| Thoracoscopy | 1 | 1998 | 60 | 0.010 |
Why?
|
| Plasmapheresis | 1 | 1998 | 24 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 1998 | 23 | 0.010 |
Why?
|
| Leukotriene E4 | 1 | 1998 | 24 | 0.010 |
Why?
|
| Sepsis | 1 | 2004 | 671 | 0.010 |
Why?
|
| Tetrahydronaphthalenes | 1 | 1998 | 34 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1998 | 60 | 0.010 |
Why?
|
| Edema | 1 | 1998 | 128 | 0.010 |
Why?
|
| Neutrophil Activation | 1 | 1998 | 84 | 0.010 |
Why?
|
| Epinephrine | 1 | 1998 | 160 | 0.010 |
Why?
|
| Syndrome | 1 | 1998 | 385 | 0.010 |
Why?
|
| Azepines | 1 | 1998 | 105 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1998 | 173 | 0.010 |
Why?
|
| Thromboembolism | 1 | 1998 | 129 | 0.010 |
Why?
|
| Hypotension | 1 | 1998 | 127 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1997 | 38 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 539 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 1998 | 228 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1997 | 88 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1998 | 306 | 0.010 |
Why?
|
| Constriction | 1 | 1997 | 45 | 0.010 |
Why?
|
| Ligation | 1 | 1997 | 91 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1998 | 166 | 0.010 |
Why?
|
| Prenatal Care | 1 | 1999 | 310 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 1997 | 60 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1998 | 251 | 0.010 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 1997 | 33 | 0.010 |
Why?
|
| Ductus Arteriosus | 1 | 1997 | 72 | 0.010 |
Why?
|
| Fever | 1 | 1998 | 320 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1998 | 190 | 0.010 |
Why?
|
| Korea | 1 | 1996 | 18 | 0.010 |
Why?
|
| Plasma | 1 | 1998 | 224 | 0.010 |
Why?
|
| Chlorobenzenes | 1 | 1996 | 18 | 0.010 |
Why?
|
| Triazoles | 1 | 1998 | 191 | 0.010 |
Why?
|
| Medical Records | 1 | 1997 | 192 | 0.010 |
Why?
|
| Japan | 1 | 1996 | 149 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 976 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1997 | 109 | 0.010 |
Why?
|
| Alkylating Agents | 1 | 1996 | 24 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1996 | 47 | 0.010 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 1997 | 139 | 0.010 |
Why?
|
| Angiotensin II | 1 | 1996 | 102 | 0.010 |
Why?
|
| China | 1 | 1996 | 278 | 0.010 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1995 | 2 | 0.010 |
Why?
|
| tert-Butylhydroperoxide | 1 | 1995 | 9 | 0.010 |
Why?
|
| Europe | 1 | 1996 | 426 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 1997 | 273 | 0.010 |
Why?
|
| Ketone Bodies | 1 | 1995 | 16 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1995 | 15 | 0.010 |
Why?
|
| Peroxides | 1 | 1995 | 18 | 0.010 |
Why?
|
| Bile | 1 | 1995 | 26 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1995 | 17 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1995 | 23 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 277 | 0.010 |
Why?
|
| Respiration | 1 | 1996 | 208 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1997 | 330 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1994 | 17 | 0.010 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 1994 | 9 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1994 | 66 | 0.010 |
Why?
|
| Autoradiography | 1 | 1994 | 66 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 2886 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 115 | 0.010 |
Why?
|
| Weight Gain | 1 | 1998 | 566 | 0.010 |
Why?
|
| Recurrence | 1 | 1998 | 1151 | 0.010 |
Why?
|
| Sinusitis | 1 | 1996 | 230 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1998 | 395 | 0.010 |
Why?
|
| Lipids | 1 | 1998 | 723 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1996 | 721 | 0.010 |
Why?
|
| Albumins | 1 | 1992 | 119 | 0.010 |
Why?
|
| Altitude | 1 | 1996 | 470 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1992 | 313 | 0.010 |
Why?
|
| Patient Selection | 1 | 1996 | 746 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 8430 | 0.000 |
Why?
|
| Cystic Fibrosis | 1 | 1998 | 1171 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2000 | 3980 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1992 | 1140 | 0.000 |
Why?
|
| Liver | 1 | 1995 | 1916 | 0.000 |
Why?
|
| Homosexuality | 1 | 1984 | 18 | 0.000 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1984 | 34 | 0.000 |
Why?
|
| Adrenal Glands | 1 | 1984 | 77 | 0.000 |
Why?
|
| Cryptococcosis | 1 | 1984 | 31 | 0.000 |
Why?
|